PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 169.0
(0.59%)
IDR 169.0
(0.59%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 51 Billion IDR | 445.04% |
| 2022 | 9.35 Billion IDR | 224.05% |
| 2021 | 2.88 Billion IDR | 48.01% |
| 2020 | 1.95 Billion IDR | -24.5% |
| 2019 | 2.58 Billion IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 34.93 Billion IDR | 16.63% |
| 2024 Q1 | 29.95 Billion IDR | -0.15% |
| 2023 Q1 | 13.74 Billion IDR | 46.93% |
| 2023 Q2 | 15.14 Billion IDR | 10.18% |
| 2023 FY | 30 Billion IDR | 220.58% |
| 2023 Q4 | 30 Billion IDR | 0.0% |
| 2023 Q3 | 30 Billion IDR | 98.02% |
| 2022 FY | 9.35 Billion IDR | 224.05% |
| 2022 Q4 | 9.35 Billion IDR | 99.17% |
| 2022 Q3 | 4.69 Billion IDR | -4.17% |
| 2022 Q2 | 4.9 Billion IDR | -41.02% |
| 2022 Q1 | 8.31 Billion IDR | 187.86% |
| 2021 Q1 | 1.27 Billion IDR | -34.74% |
| 2021 FY | 2.88 Billion IDR | 48.01% |
| 2021 Q3 | 2.23 Billion IDR | 75.34% |
| 2021 Q4 | 2.88 Billion IDR | 29.35% |
| 2021 Q2 | 1.27 Billion IDR | 0.0% |
| 2020 Q1 | - IDR | -100.0% |
| 2020 FY | 1.95 Billion IDR | -24.5% |
| 2020 Q4 | 1.95 Billion IDR | 0.0% |
| 2020 Q2 | 1.62 Billion IDR | 0.0% |
| 2019 Q4 | 2.58 Billion IDR | 0.0% |
| 2019 FY | 2.58 Billion IDR | 0.0% |
| 2019 Q3 | 2.58 Billion IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2017 FY | - IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Prodia Widyahusada Tbk | 18.43 Billion IDR | -176.701% |